comparison of glp-1 agonists Treatment with Receptor GLP-1-based therapies: current knowledge of
Description
E., Hayes, M
Tirzepatide was groundbreaking as the first dual GIP/GLP-1 receptor agonist, but it is no longer the only advanced option available
Furthermore, the administration of exogenous GLP-1 resulted in elevated calcitonin expression in the thyroids of normal (wild-type) mice
Because these agents are longer-acting, they produce more consistent activation of GLP-1 receptors
PubMed, de Graaf, Chris, et al
